ServX

Company Overview

Snapshot

Founded in January 2016 by Hanan Khamis, Rani B. Zananiri, Nesma Mazzawi, Asaf Romano, and Daniel Komornik, ServX operates with 1–10 employees. The company has secured funding across one round from three investors, including AltaIR Capital. In January 2017, ServX completed a Seed funding round.

Business overview

ServX is developing a novel, home-based, real-time cervical dilation monitor. This solution aims to provide crucial information regarding the onset of active labor for both term and preterm deliveries. The technology is designed to reduce the need for frequent hospital visits and repeated vaginal examinations, thereby mitigating infection risks and enabling a rapid response, particularly for preterm cases. ServX operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Monitors segment within Medical Devices, and serves consumers in the Demographics & Family market, focusing on women.

Company Intelligence Q&A

What is ServX's primary product?

ServX is developing a novel, home-based, and real-time cervical dilation monitor designed to provide crucial information on the onset of active labor for both term and preterm deliveries.

When was ServX founded and by whom?

ServX was founded in January 2016 by Hanan Khamis, Rani B. Zananiri, Nesma Mazzawi, Asaf Romano, and Daniel Komornik.

What is the primary sector ServX operates in?

ServX operates within the Health Tech & Life Sciences sector, focusing on Medical Devices and Medical Monitors.

What is the current employee size of ServX?

ServX currently has 1–10 employees.

Has ServX received any funding?

ServX completed a Seed funding round in January 2017, with participation from investors including AltaIR Capital and Igor Ryabenkiy.